Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study have?
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study has 63 citations in the OpenAlex counts ScholarIQ stores.
When was Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study published?
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study has 2021 year in the ScholarIQ index.
What is the open-access status of Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study?
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study has green oa status in the ScholarIQ index.
What is the DOI of Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study?
The DOI for Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study is on the source record.
What is the PMID of Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study?
The PMID for Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study is on the source record.
What is the OpenAlex record for Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study?
The OpenAlex for Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study is on the source record.